Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126922971 | 12692297 | 1 | I | 20160822 | 20160828 | 20160828 | EXP | TW-MYLANLABS-2016M1035924 | MYLAN | YANG C-W, CHO Y-T, CHEN K-L, CHEN Y-C, SONG H-L, CHU C-Y. LONG-TERM SEQUELAE OF STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS. ACTA-DERM-VENEREOL 2016;96(4):525-529. | 0.00 | Y | 0.00000 | 20160828 | OT | TW | TW |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126922971 | 12692297 | 1 | PS | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | U | U | 18659 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126922971 | 12692297 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126922971 | 12692297 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126922971 | 12692297 | Interstitial lung disease | |
| 126922971 | 12692297 | Stevens-Johnson syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |